

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NIK/NF-kappaB signaling (GO:0038061) | 6.01374589 |
| 2 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.53335000 |
| 3 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.52295230 |
| 4 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.52295230 |
| 5 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.37809003 |
| 6 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.16176274 |
| 7 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 4.72313232 |
| 8 | myeloid dendritic cell differentiation (GO:0043011) | 4.43558165 |
| 9 | myeloid dendritic cell activation (GO:0001773) | 4.37634372 |
| 10 | response to muramyl dipeptide (GO:0032495) | 4.22096537 |
| 11 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 4.20982394 |
| 12 | negative thymic T cell selection (GO:0045060) | 4.19655200 |
| 13 | neutrophil activation involved in immune response (GO:0002283) | 4.13302023 |
| 14 | negative T cell selection (GO:0043383) | 4.08184686 |
| 15 | positive regulation of natural killer cell differentiation (GO:0032825) | 4.00470956 |
| 16 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 3.98601769 |
| 17 | positive T cell selection (GO:0043368) | 3.92548636 |
| 18 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.77687315 |
| 19 | regulation of gamma-delta T cell activation (GO:0046643) | 3.76042978 |
| 20 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.69360519 |
| 21 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.69175723 |
| 22 | positive regulation of interleukin-2 production (GO:0032743) | 3.68420901 |
| 23 | positive regulation of antigen processing and presentation (GO:0002579) | 3.63172035 |
| 24 | positive regulation of granulocyte differentiation (GO:0030854) | 3.62564515 |
| 25 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.61798834 |
| 26 | neutrophil activation (GO:0042119) | 3.61699409 |
| 27 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.56382995 |
| 28 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.53868204 |
| 29 | dendritic cell differentiation (GO:0097028) | 3.50847037 |
| 30 | negative regulation of T cell mediated immunity (GO:0002710) | 3.50832996 |
| 31 | negative regulation of interleukin-12 production (GO:0032695) | 3.49917935 |
| 32 | granulocyte activation (GO:0036230) | 3.47029398 |
| 33 | T cell migration (GO:0072678) | 3.44823582 |
| 34 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.43828689 |
| 35 | positive regulation of tolerance induction (GO:0002645) | 3.43741361 |
| 36 | regulation of T cell tolerance induction (GO:0002664) | 3.42541726 |
| 37 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 3.42320613 |
| 38 | positive regulation of humoral immune response (GO:0002922) | 3.39994071 |
| 39 | response to type I interferon (GO:0034340) | 3.39114690 |
| 40 | type I interferon signaling pathway (GO:0060337) | 3.38664859 |
| 41 | cellular response to type I interferon (GO:0071357) | 3.38664859 |
| 42 | positive regulation of interleukin-12 production (GO:0032735) | 3.36806605 |
| 43 | immunoglobulin mediated immune response (GO:0016064) | 3.35448495 |
| 44 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 3.33718773 |
| 45 | positive regulation of B cell differentiation (GO:0045579) | 3.32064529 |
| 46 | regulation of RIG-I signaling pathway (GO:0039535) | 3.29329566 |
| 47 | cellular extravasation (GO:0045123) | 3.28654058 |
| 48 | regulation of antigen processing and presentation (GO:0002577) | 3.28209745 |
| 49 | regulation of isotype switching to IgG isotypes (GO:0048302) | 3.26003316 |
| 50 | thymic T cell selection (GO:0045061) | 3.24923441 |
| 51 | regulation of germinal center formation (GO:0002634) | 3.23585941 |
| 52 | regulation of regulatory T cell differentiation (GO:0045589) | 3.22819915 |
| 53 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.22738028 |
| 54 | tolerance induction (GO:0002507) | 3.21388780 |
| 55 | response to interleukin-15 (GO:0070672) | 3.21262585 |
| 56 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.20457624 |
| 57 | response to peptidoglycan (GO:0032494) | 3.17239773 |
| 58 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.16555516 |
| 59 | leukocyte aggregation (GO:0070486) | 3.16203637 |
| 60 | natural killer cell mediated cytotoxicity (GO:0042267) | 3.14824023 |
| 61 | natural killer cell mediated immunity (GO:0002228) | 3.14824023 |
| 62 | negative regulation of bone resorption (GO:0045779) | 3.14695530 |
| 63 | interferon-gamma production (GO:0032609) | 3.14479947 |
| 64 | natural killer cell differentiation (GO:0001779) | 3.10562207 |
| 65 | regulation of hypersensitivity (GO:0002883) | 3.10116942 |
| 66 | T cell selection (GO:0045058) | 3.09712869 |
| 67 | positive regulation of interferon-alpha production (GO:0032727) | 3.09053426 |
| 68 | cellular response to interleukin-15 (GO:0071350) | 3.08056822 |
| 69 | regulation of B cell differentiation (GO:0045577) | 3.07928224 |
| 70 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.07512991 |
| 71 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.06849763 |
| 72 | regulation of tolerance induction (GO:0002643) | 3.06788980 |
| 73 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 3.06700514 |
| 74 | negative regulation of interleukin-1 beta production (GO:0032691) | 3.06160561 |
| 75 | negative regulation of innate immune response (GO:0045824) | 3.05678978 |
| 76 | mature B cell differentiation (GO:0002335) | 3.02762474 |
| 77 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.02187170 |
| 78 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 3.02122421 |
| 79 | regulation of interleukin-12 production (GO:0032655) | 3.02036561 |
| 80 | positive regulation of isotype switching (GO:0045830) | 3.01200269 |
| 81 | regulation of alpha-beta T cell activation (GO:0046634) | 3.00836479 |
| 82 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.00193359 |
| 83 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.00193359 |
| 84 | germinal center formation (GO:0002467) | 2.99907699 |
| 85 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.99784844 |
| 86 | negative regulation of cell killing (GO:0031342) | 2.99784844 |
| 87 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.99604005 |
| 88 | response to protozoan (GO:0001562) | 2.99046350 |
| 89 | regulation of interferon-alpha production (GO:0032647) | 2.98921050 |
| 90 | positive thymic T cell selection (GO:0045059) | 2.98153104 |
| 91 | T-helper 1 type immune response (GO:0042088) | 2.98107454 |
| 92 | cellular response to interferon-beta (GO:0035458) | 2.98069846 |
| 93 | natural killer cell activation (GO:0030101) | 2.98011670 |
| 94 | growth hormone receptor signaling pathway (GO:0060396) | 2.96088565 |
| 95 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.95877165 |
| 96 | positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516) | 2.95474196 |
| 97 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.95048130 |
| 98 | regulation of necroptotic process (GO:0060544) | 2.95045384 |
| 99 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 2.94773244 |
| 100 | positive regulation of T cell cytokine production (GO:0002726) | 2.94628804 |
| 101 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.94274519 |
| 102 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.94274519 |
| 103 | modulation by symbiont of host immune response (GO:0052553) | 2.94274519 |
| 104 | positive regulation by symbiont of host defense response (GO:0052509) | 2.94274519 |
| 105 | modulation by symbiont of host defense response (GO:0052031) | 2.94274519 |
| 106 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.94274519 |
| 107 | hepatocyte apoptotic process (GO:0097284) | 2.92883493 |
| 108 | detection of other organism (GO:0098543) | 2.92576100 |
| 109 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.92287902 |
| 110 | positive regulation of alpha-beta T cell differentiation (GO:0046638) | 2.91905253 |
| 111 | regulation of alpha-beta T cell differentiation (GO:0046637) | 2.91624927 |
| 112 | B cell mediated immunity (GO:0019724) | 2.90075937 |
| 113 | mature B cell differentiation involved in immune response (GO:0002313) | 2.90056068 |
| 114 | B cell receptor signaling pathway (GO:0050853) | 2.89570099 |
| 115 | mast cell activation (GO:0045576) | 2.89303937 |
| 116 | defense response to protozoan (GO:0042832) | 2.88371188 |
| 117 | lymphocyte migration (GO:0072676) | 2.87320587 |
| 118 | regulation of granulocyte differentiation (GO:0030852) | 2.87021315 |
| 119 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.86765326 |
| 120 | * CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 2.86519850 |
| 121 | * T-helper cell differentiation (GO:0042093) | 2.86519850 |
| 122 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.86128830 |
| 123 | negative regulation of interleukin-6 production (GO:0032715) | 2.86013321 |
| 124 | regulation of interleukin-2 production (GO:0032663) | 2.85832043 |
| 125 | regulation of immunoglobulin secretion (GO:0051023) | 2.84946839 |
| 126 | mucosal-associated lymphoid tissue development (GO:0048537) | 2.84768006 |
| 127 | Peyers patch development (GO:0048541) | 2.84768006 |
| 128 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.84624242 |
| 129 | regulation of response to interferon-gamma (GO:0060330) | 2.84516623 |
| 130 | T cell receptor signaling pathway (GO:0050852) | 2.84254152 |
| 131 | * alpha-beta T cell differentiation (GO:0046632) | 2.84155602 |
| 132 | positive regulation of alpha-beta T cell activation (GO:0046635) | 2.83919590 |
| 133 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.83768861 |
| 134 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.83517630 |
| 135 | response to interferon-beta (GO:0035456) | 2.82142423 |
| 136 | positive regulation of macrophage differentiation (GO:0045651) | 2.81660649 |
| 137 | regulation of chronic inflammatory response (GO:0002676) | 2.81435344 |
| 138 | regulation of CD4-positive, alpha-beta T cell activation (GO:2000514) | 2.80081497 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 5.88735817 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.85751050 |
| 3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.62416486 |
| 4 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.36224581 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.14704136 |
| 6 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.89366772 |
| 7 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.68887326 |
| 8 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.68389905 |
| 9 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.40123387 |
| 10 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.40027280 |
| 11 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.31507679 |
| 12 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.22655388 |
| 13 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.16203900 |
| 14 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.93844145 |
| 15 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.89011661 |
| 16 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.86116805 |
| 17 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.85260967 |
| 18 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.84151259 |
| 19 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.83538051 |
| 20 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.68625738 |
| 21 | * MYB_26560356_Chip-Seq_TH2_Human | 2.52526558 |
| 22 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.37295292 |
| 23 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.36732416 |
| 24 | * MAF_26560356_Chip-Seq_TH1_Human | 2.34007510 |
| 25 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.13862300 |
| 26 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.12433764 |
| 27 | * MYB_26560356_Chip-Seq_TH1_Human | 2.10990389 |
| 28 | * VDR_21846776_ChIP-Seq_THP-1_Human | 2.08303677 |
| 29 | MYC_22102868_ChIP-Seq_BL_Human | 2.07562725 |
| 30 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.03711357 |
| 31 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.97261779 |
| 32 | * VDR_24763502_ChIP-Seq_THP-1_Human | 1.94577224 |
| 33 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.94037786 |
| 34 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.92492475 |
| 35 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.91831426 |
| 36 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.87378294 |
| 37 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.79432680 |
| 38 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.78144540 |
| 39 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.76872553 |
| 40 | UTX_26944678_Chip-Seq_JUKART_Human | 1.73486597 |
| 41 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.73408535 |
| 42 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.57011883 |
| 43 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.55547179 |
| 44 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.55492819 |
| 45 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.49697424 |
| 46 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.47895352 |
| 47 | SPI1_23127762_ChIP-Seq_K562_Human | 1.44904543 |
| 48 | * VDR_24787735_ChIP-Seq_THP-1_Human | 1.43220779 |
| 49 | MAF_26560356_Chip-Seq_TH2_Human | 1.42010134 |
| 50 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.39936688 |
| 51 | GATA1_22025678_ChIP-Seq_K562_Human | 1.38257746 |
| 52 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.36167365 |
| 53 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.35471260 |
| 54 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.33907961 |
| 55 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.32547000 |
| 56 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.27771876 |
| 57 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.26842665 |
| 58 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.26079831 |
| 59 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.24820143 |
| 60 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.24442085 |
| 61 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.24391787 |
| 62 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.20494799 |
| 63 | GATA3_26560356_Chip-Seq_TH2_Human | 1.19368281 |
| 64 | * VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.17740324 |
| 65 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.17699032 |
| 66 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.15659028 |
| 67 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.15371257 |
| 68 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.13471379 |
| 69 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.11332614 |
| 70 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.09653820 |
| 71 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.09149665 |
| 72 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.04304251 |
| 73 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.03987700 |
| 74 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.02462019 |
| 75 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.02462019 |
| 76 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.02462019 |
| 77 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.01741840 |
| 78 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.01571921 |
| 79 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.01401214 |
| 80 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.00408792 |
| 81 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.99845677 |
| 82 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.95590206 |
| 83 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.95590206 |
| 84 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.93597390 |
| 85 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.93344970 |
| 86 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.92600418 |
| 87 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.90290914 |
| 88 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.89512161 |
| 89 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.87889464 |
| 90 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.87862271 |
| 91 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.86531879 |
| 92 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.85714461 |
| 93 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.85145659 |
| 94 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.84383527 |
| 95 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.82719771 |
| 96 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.82324672 |
| 97 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.81879653 |
| 98 | * FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.81019782 |
| 99 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.80255819 |
| 100 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.79720811 |
| 101 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.79120823 |
| 102 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.77611807 |
| 103 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.76031012 |
| 104 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.75743613 |
| 105 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.74333419 |
| 106 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.74189162 |
| 107 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.72113794 |
| 108 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.71174544 |
| 109 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.71041904 |
| 110 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.70946176 |
| 111 | GATA2_19941826_ChIP-Seq_K562_Human | 0.70245894 |
| 112 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.69286316 |
| 113 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.68822389 |
| 114 | GATA1_19941826_ChIP-Seq_K562_Human | 0.67343823 |
| 115 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.64753253 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.46171524 |
| 2 | MP0000685_abnormal_immune_system | 3.86048480 |
| 3 | MP0005671_abnormal_response_to | 3.41145829 |
| 4 | MP0009785_altered_susceptibility_to | 3.17150940 |
| 5 | MP0001790_abnormal_immune_system | 3.11646232 |
| 6 | MP0005387_immune_system_phenotype | 3.11646232 |
| 7 | * MP0002148_abnormal_hypersensitivity_rea | 3.03691387 |
| 8 | * MP0003436_decreased_susceptibility_to | 3.03305572 |
| 9 | * MP0005000_abnormal_immune_tolerance | 2.96247931 |
| 10 | MP0004510_myositis | 2.93245033 |
| 11 | MP0001800_abnormal_humoral_immune | 2.91450327 |
| 12 | MP0002254_reproductive_system_inflammat | 2.89200712 |
| 13 | MP0002138_abnormal_hepatobiliary_system | 2.77450958 |
| 14 | * MP0002452_abnormal_antigen_presenting | 2.69580543 |
| 15 | * MP0002723_abnormal_immune_serum | 2.63501569 |
| 16 | MP0005025_abnormal_response_to | 2.61580883 |
| 17 | * MP0002166_altered_tumor_susceptibility | 2.54799998 |
| 18 | MP0003763_abnormal_thymus_physiology | 2.49630929 |
| 19 | * MP0001819_abnormal_immune_cell | 2.47419822 |
| 20 | * MP0002420_abnormal_adaptive_immunity | 2.46634275 |
| 21 | * MP0002419_abnormal_innate_immunity | 2.44086229 |
| 22 | MP0003303_peritoneal_inflammation | 2.27625622 |
| 23 | * MP0002006_tumorigenesis | 2.25898744 |
| 24 | MP0001873_stomach_inflammation | 2.24443492 |
| 25 | MP0004947_skin_inflammation | 2.15000556 |
| 26 | MP0002405_respiratory_system_inflammati | 2.14086870 |
| 27 | * MP0002398_abnormal_bone_marrow | 2.10469522 |
| 28 | MP0010155_abnormal_intestine_physiology | 2.02420775 |
| 29 | * MP0000716_abnormal_immune_system | 1.99865549 |
| 30 | MP0006082_CNS_inflammation | 1.99126051 |
| 31 | MP0003300_gastrointestinal_ulcer | 1.96513662 |
| 32 | MP0001853_heart_inflammation | 1.96354787 |
| 33 | MP0002396_abnormal_hematopoietic_system | 1.93998205 |
| 34 | MP0005310_abnormal_salivary_gland | 1.90626209 |
| 35 | MP0003724_increased_susceptibility_to | 1.90582434 |
| 36 | MP0005464_abnormal_platelet_physiology | 1.73991557 |
| 37 | MP0009333_abnormal_splenocyte_physiolog | 1.72621907 |
| 38 | MP0001845_abnormal_inflammatory_respons | 1.72075210 |
| 39 | MP0000689_abnormal_spleen_morphology | 1.67796271 |
| 40 | MP0002722_abnormal_immune_system | 1.67583250 |
| 41 | MP0001348_abnormal_lacrimal_gland | 1.66172307 |
| 42 | * MP0002429_abnormal_blood_cell | 1.62773327 |
| 43 | MP0002163_abnormal_gland_morphology | 1.59297150 |
| 44 | MP0001545_abnormal_hematopoietic_system | 1.54919799 |
| 45 | MP0005397_hematopoietic_system_phenotyp | 1.54919799 |
| 46 | MP0003866_abnormal_defecation | 1.49402710 |
| 47 | MP0004808_abnormal_hematopoietic_stem | 1.47326769 |
| 48 | MP0003448_altered_tumor_morphology | 1.43241750 |
| 49 | MP0002277_abnormal_respiratory_mucosa | 1.43160072 |
| 50 | MP0000703_abnormal_thymus_morphology | 1.40143270 |
| 51 | * MP0001533_abnormal_skeleton_physiology | 1.39550327 |
| 52 | MP0010352_gastrointestinal_tract_polyps | 1.38190734 |
| 53 | MP0002877_abnormal_melanocyte_morpholog | 1.36923279 |
| 54 | MP0000858_altered_metastatic_potential | 1.29402445 |
| 55 | * MP0008469_abnormal_protein_level | 1.28525842 |
| 56 | MP0009764_decreased_sensitivity_to | 1.26526376 |
| 57 | MP0005174_abnormal_tail_pigmentation | 1.26058123 |
| 58 | MP0005076_abnormal_cell_differentiation | 1.24742618 |
| 59 | MP0000569_abnormal_digit_pigmentation | 1.24610993 |
| 60 | MP0003656_abnormal_erythrocyte_physiolo | 1.20376343 |
| 61 | MP0009278_abnormal_bone_marrow | 1.17502985 |
| 62 | MP0000490_abnormal_crypts_of | 1.14007743 |
| 63 | MP0005166_decreased_susceptibility_to | 1.13562258 |
| 64 | MP0003453_abnormal_keratinocyte_physiol | 1.11856640 |
| 65 | * MP0002998_abnormal_bone_remodeling | 1.00107265 |
| 66 | MP0004381_abnormal_hair_follicle | 0.99655923 |
| 67 | * MP0002933_joint_inflammation | 0.99477936 |
| 68 | MP0008057_abnormal_DNA_replication | 0.98364384 |
| 69 | MP0000465_gastrointestinal_hemorrhage | 0.97177014 |
| 70 | MP0003091_abnormal_cell_migration | 0.85549824 |
| 71 | MP0001663_abnormal_digestive_system | 0.85432625 |
| 72 | MP0001501_abnormal_sleep_pattern | 0.85018554 |
| 73 | MP0001851_eye_inflammation | 0.83537520 |
| 74 | * MP0002009_preneoplasia | 0.83285543 |
| 75 | MP0001346_abnormal_lacrimal_gland | 0.82786573 |
| 76 | MP0009765_abnormal_xenobiotic_induced | 0.81667543 |
| 77 | MP0004883_abnormal_blood_vessel | 0.78851678 |
| 78 | MP0003566_abnormal_cell_adhesion | 0.78438940 |
| 79 | MP0005451_abnormal_body_composition | 0.76655706 |
| 80 | MP0001881_abnormal_mammary_gland | 0.76583412 |
| 81 | MP0008961_abnormal_basal_metabolism | 0.75005290 |
| 82 | MP0000343_altered_response_to | 0.74966114 |
| 83 | MP0001216_abnormal_epidermal_layer | 0.74550981 |
| 84 | MP0005164_abnormal_response_to | 0.74307003 |
| 85 | MP0005058_abnormal_lysosome_morphology | 0.74176539 |
| 86 | MP0003828_pulmonary_edema | 0.74027697 |
| 87 | MP0008004_abnormal_stomach_pH | 0.73212972 |
| 88 | * MP0002019_abnormal_tumor_incidence | 0.70786611 |
| 89 | MP0009763_increased_sensitivity_to | 0.69177483 |
| 90 | * MP0005390_skeleton_phenotype | 0.67964920 |
| 91 | MP0000604_amyloidosis | 0.67168177 |
| 92 | MP0002132_abnormal_respiratory_system | 0.66209122 |
| 93 | MP0000627_abnormal_mammary_gland | 0.66088984 |
| 94 | MP0000371_diluted_coat_color | 0.65528101 |
| 95 | MP0002136_abnormal_kidney_physiology | 0.64479439 |
| 96 | MP0009840_abnormal_foam_cell | 0.63976138 |
| 97 | MP0003191_abnormal_cellular_cholesterol | 0.63831579 |
| 98 | * MP0000249_abnormal_blood_vessel | 0.63819478 |
| 99 | MP0001191_abnormal_skin_condition | 0.63105495 |
| 100 | MP0008260_abnormal_autophagy | 0.62790118 |
| 101 | MP0005167_abnormal_blood-brain_barrier | 0.62522410 |
| 102 | MP0000767_abnormal_smooth_muscle | 0.61867831 |
| 103 | MP0001243_abnormal_dermal_layer | 0.61077172 |
| 104 | MP0003075_altered_response_to | 0.60444366 |
| 105 | MP0003172_abnormal_lysosome_physiology | 0.59579421 |
| 106 | MP0010307_abnormal_tumor_latency | 0.58484276 |
| 107 | MP0003183_abnormal_peptide_metabolism | 0.58250592 |
| 108 | MP0005379_endocrine/exocrine_gland_phen | 0.57971916 |
| 109 | MP0002095_abnormal_skin_pigmentation | 0.57814860 |
| 110 | MP0005075_abnormal_melanosome_morpholog | 0.56908390 |
| 111 | MP0004130_abnormal_muscle_cell | 0.55326693 |
| 112 | MP0001919_abnormal_reproductive_system | 0.54869194 |
| 113 | MP0008007_abnormal_cellular_replicative | 0.54772097 |
| 114 | * MP0003795_abnormal_bone_structure | 0.54751240 |
| 115 | * MP0000609_abnormal_liver_physiology | 0.54171273 |
| 116 | MP0002693_abnormal_pancreas_physiology | 0.53252908 |
| 117 | MP0003045_fibrosis | 0.51714602 |
| 118 | MP0001542_abnormal_bone_strength | 0.51313827 |
| 119 | MP0005023_abnormal_wound_healing | 0.51073268 |
| 120 | MP0003690_abnormal_glial_cell | 0.50997383 |
| 121 | MP0003279_aneurysm | 0.50583100 |
| 122 | MP0005535_abnormal_body_temperature | 0.49027745 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Myositis (HP:0100614) | 5.02911818 |
| 2 | Eczematoid dermatitis (HP:0000976) | 4.90984703 |
| 3 | Recurrent abscess formation (HP:0002722) | 4.84190335 |
| 4 | Recurrent fungal infections (HP:0002841) | 4.67648006 |
| 5 | Recurrent bacterial skin infections (HP:0005406) | 4.64531758 |
| 6 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.64467168 |
| 7 | Retrobulbar optic neuritis (HP:0100654) | 4.62028295 |
| 8 | Optic neuritis (HP:0100653) | 4.62028295 |
| 9 | Orchitis (HP:0100796) | 4.58197980 |
| 10 | Recurrent viral infections (HP:0004429) | 4.46288085 |
| 11 | Chronic otitis media (HP:0000389) | 4.45292767 |
| 12 | Autoimmune thrombocytopenia (HP:0001973) | 4.20758750 |
| 13 | Thrombocytosis (HP:0001894) | 3.81922236 |
| 14 | Mediastinal lymphadenopathy (HP:0100721) | 3.75827024 |
| 15 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.69635625 |
| 16 | Vasculitis (HP:0002633) | 3.66969207 |
| 17 | Nasal polyposis (HP:0100582) | 3.54858348 |
| 18 | Arterial thrombosis (HP:0004420) | 3.53870274 |
| 19 | Increased IgM level (HP:0003496) | 3.51151860 |
| 20 | Abnormality of macrophages (HP:0004311) | 3.41589288 |
| 21 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.40838839 |
| 22 | Recurrent cutaneous fungal infections (HP:0011370) | 3.40838839 |
| 23 | Recurrent skin infections (HP:0001581) | 3.39841626 |
| 24 | Abnormality of T cell number (HP:0011839) | 3.39652367 |
| 25 | Gastrointestinal infarctions (HP:0005244) | 3.27865919 |
| 26 | Pulmonary infiltrates (HP:0002113) | 3.25612122 |
| 27 | Eosinophilia (HP:0001880) | 3.21282421 |
| 28 | Abnormality of the nasal mucosa (HP:0000433) | 3.18701117 |
| 29 | Stomach cancer (HP:0012126) | 3.18282385 |
| 30 | Recurrent bronchitis (HP:0002837) | 3.12036698 |
| 31 | Fatigue (HP:0012378) | 3.11853317 |
| 32 | Leukocytosis (HP:0001974) | 3.11633724 |
| 33 | Stomatitis (HP:0010280) | 3.06484042 |
| 34 | Periodontitis (HP:0000704) | 3.06397513 |
| 35 | Abnormality of T cells (HP:0002843) | 3.05456537 |
| 36 | Panhypogammaglobulinemia (HP:0003139) | 3.04951374 |
| 37 | Abnormality of T cell physiology (HP:0011840) | 3.00985358 |
| 38 | T lymphocytopenia (HP:0005403) | 2.99781559 |
| 39 | Autoimmune hemolytic anemia (HP:0001890) | 2.98730151 |
| 40 | Increased IgE level (HP:0003212) | 2.98566547 |
| 41 | Pustule (HP:0200039) | 2.98219232 |
| 42 | Meningitis (HP:0001287) | 2.97986339 |
| 43 | IgM deficiency (HP:0002850) | 2.91661022 |
| 44 | Agammaglobulinemia (HP:0004432) | 2.89149613 |
| 45 | Keratoconjunctivitis sicca (HP:0001097) | 2.87491114 |
| 46 | Granulocytopenia (HP:0001913) | 2.87135900 |
| 47 | Hypergammaglobulinemia (HP:0010702) | 2.85589475 |
| 48 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.85169393 |
| 49 | Cellulitis (HP:0100658) | 2.79969767 |
| 50 | Hemoptysis (HP:0002105) | 2.75409735 |
| 51 | Abnormality of eosinophils (HP:0001879) | 2.74746117 |
| 52 | Inflammation of the large intestine (HP:0002037) | 2.74240112 |
| 53 | Obstructive lung disease (HP:0006536) | 2.72375868 |
| 54 | Chronic obstructive pulmonary disease (HP:0006510) | 2.72375868 |
| 55 | Colitis (HP:0002583) | 2.67228589 |
| 56 | Chronic diarrhea (HP:0002028) | 2.65511686 |
| 57 | Spontaneous hematomas (HP:0007420) | 2.64343203 |
| 58 | Hematochezia (HP:0002573) | 2.63300311 |
| 59 | Gastrointestinal inflammation (HP:0004386) | 2.63222046 |
| 60 | Myocardial infarction (HP:0001658) | 2.62918205 |
| 61 | Keratoconjunctivitis (HP:0001096) | 2.62192164 |
| 62 | Dysostosis multiplex (HP:0000943) | 2.58935612 |
| 63 | Severe combined immunodeficiency (HP:0004430) | 2.58123013 |
| 64 | Thyroiditis (HP:0100646) | 2.55667027 |
| 65 | Gingivitis (HP:0000230) | 2.53104989 |
| 66 | Abnormality of the fingertips (HP:0001211) | 2.52695281 |
| 67 | Encephalitis (HP:0002383) | 2.52235355 |
| 68 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.48720985 |
| 69 | Pulmonary embolism (HP:0002204) | 2.47519463 |
| 70 | B lymphocytopenia (HP:0010976) | 2.47452635 |
| 71 | Abnormality of B cell number (HP:0010975) | 2.47452635 |
| 72 | Gingival bleeding (HP:0000225) | 2.47338199 |
| 73 | Chest pain (HP:0100749) | 2.47288220 |
| 74 | Abnormality of glycolipid metabolism (HP:0010969) | 2.46608986 |
| 75 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.46608986 |
| 76 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.46608986 |
| 77 | IgG deficiency (HP:0004315) | 2.43305002 |
| 78 | Interstitial pulmonary disease (HP:0006530) | 2.43245291 |
| 79 | IgA deficiency (HP:0002720) | 2.38613292 |
| 80 | Lymphopenia (HP:0001888) | 2.37423161 |
| 81 | Petechiae (HP:0000967) | 2.36392291 |
| 82 | Increased cerebral lipofuscin (HP:0011813) | 2.33376754 |
| 83 | Combined immunodeficiency (HP:0005387) | 2.30975014 |
| 84 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.30752331 |
| 85 | Osteolytic defects of the hand bones (HP:0009699) | 2.30752331 |
| 86 | Epistaxis (HP:0000421) | 2.28566082 |
| 87 | Amaurosis fugax (HP:0100576) | 2.28430427 |
| 88 | Glomerulopathy (HP:0100820) | 2.26005448 |
| 89 | Peritonitis (HP:0002586) | 2.25948059 |
| 90 | Vacuolated lymphocytes (HP:0001922) | 2.25491426 |
| 91 | Basal ganglia calcification (HP:0002135) | 2.21308796 |
| 92 | Prostate neoplasm (HP:0100787) | 2.20988083 |
| 93 | Polycythemia (HP:0001901) | 2.17712420 |
| 94 | Joint swelling (HP:0001386) | 2.16931349 |
| 95 | Verrucae (HP:0200043) | 2.16728537 |
| 96 | Papilloma (HP:0012740) | 2.16728537 |
| 97 | Skin ulcer (HP:0200042) | 2.15632525 |
| 98 | Gastrointestinal stroma tumor (HP:0100723) | 2.14900719 |
| 99 | Episodic fever (HP:0001954) | 2.11845162 |
| 100 | Amyloidosis (HP:0011034) | 2.09521938 |
| 101 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.09431495 |
| 102 | Osteomyelitis (HP:0002754) | 2.08786174 |
| 103 | Abnormality of the prostate (HP:0008775) | 2.07952560 |
| 104 | Acute myeloid leukemia (HP:0004808) | 2.07629797 |
| 105 | Anorexia (HP:0002039) | 2.06580222 |
| 106 | Spondylolisthesis (HP:0003302) | 2.05629624 |
| 107 | Alveolar cell carcinoma (HP:0006519) | 2.05299391 |
| 108 | Loss of speech (HP:0002371) | 2.03929696 |
| 109 | Gangrene (HP:0100758) | 2.02754625 |
| 110 | Chronic sinusitis (HP:0011109) | 2.02677291 |
| 111 | Arthralgia (HP:0002829) | 2.02641372 |
| 112 | Emphysema (HP:0002097) | 2.01588083 |
| 113 | Abnormality of the pleura (HP:0002103) | 2.00970952 |
| 114 | Papilledema (HP:0001085) | 2.00597143 |
| 115 | Albinism (HP:0001022) | 1.99795843 |
| 116 | Prolonged bleeding time (HP:0003010) | 1.98638402 |
| 117 | Hypoplasia of the thymus (HP:0000778) | 1.98085335 |
| 118 | Esophageal varix (HP:0002040) | 1.97713050 |
| 119 | Recurrent pneumonia (HP:0006532) | 1.96780663 |
| 120 | Vertebral compression fractures (HP:0002953) | 1.95328575 |
| 121 | Polyneuropathy (HP:0001271) | 1.94203468 |
| 122 | Urticaria (HP:0001025) | 1.94190052 |
| 123 | Neoplasm of the tracheobronchial system (HP:0100552) | 1.91946575 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K14 | 4.76982091 |
| 2 | JAK3 | 3.77877353 |
| 3 | MAP4K1 | 3.72576748 |
| 4 | TYK2 | 3.33045734 |
| 5 | IKBKB | 3.22687347 |
| 6 | TBK1 | 3.07560638 |
| 7 | TXK | 2.84657999 |
| 8 | IKBKE | 2.72910015 |
| 9 | MAP3K13 | 2.62184754 |
| 10 | CHUK | 2.37957839 |
| 11 | IRAK4 | 2.35979565 |
| 12 | PRPF4B | 2.34869163 |
| 13 | KIT | 2.16890302 |
| 14 | JAK1 | 2.10204605 |
| 15 | IRAK3 | 2.02495331 |
| 16 | RIPK4 | 2.01600653 |
| 17 | ZAP70 | 1.97090083 |
| 18 | STK10 | 1.79807430 |
| 19 | BLK | 1.68368151 |
| 20 | PIM2 | 1.68357534 |
| 21 | FGFR4 | 1.64341780 |
| 22 | MST4 | 1.60681574 |
| 23 | FGFR3 | 1.49068412 |
| 24 | BTK | 1.48646168 |
| 25 | SYK | 1.45832461 |
| 26 | PIM1 | 1.44394610 |
| 27 | EPHB1 | 1.42644256 |
| 28 | TEC | 1.39680778 |
| 29 | TESK2 | 1.37642928 |
| 30 | CSF1R | 1.37572836 |
| 31 | LCK | 1.36914442 |
| 32 | FLT3 | 1.32132381 |
| 33 | NLK | 1.29797781 |
| 34 | ITK | 1.28300702 |
| 35 | TNK2 | 1.25290333 |
| 36 | TGFBR2 | 1.20415899 |
| 37 | LRRK2 | 1.20328725 |
| 38 | JAK2 | 1.18160678 |
| 39 | RPS6KA4 | 1.15704455 |
| 40 | MAPK7 | 1.14075496 |
| 41 | CSK | 1.13888402 |
| 42 | ERN1 | 1.13160976 |
| 43 | GRK7 | 1.11566399 |
| 44 | HCK | 1.08996420 |
| 45 | CAMKK2 | 1.08631475 |
| 46 | TGFBR1 | 1.08098507 |
| 47 | GRK6 | 1.07984519 |
| 48 | MAP2K3 | 1.07791429 |
| 49 | MAP3K10 | 1.07691101 |
| 50 | EPHA3 | 1.05818338 |
| 51 | EEF2K | 0.95752601 |
| 52 | PTK6 | 0.89317990 |
| 53 | NME2 | 0.86843965 |
| 54 | SIK3 | 0.85564044 |
| 55 | STK4 | 0.84294043 |
| 56 | IRAK1 | 0.82497388 |
| 57 | MAP3K3 | 0.82420666 |
| 58 | MAPK15 | 0.82263784 |
| 59 | NEK9 | 0.79653735 |
| 60 | BMPR2 | 0.78972379 |
| 61 | TAOK2 | 0.76811156 |
| 62 | SIK2 | 0.75310992 |
| 63 | MAPKAPK2 | 0.74597917 |
| 64 | TRPM7 | 0.73496928 |
| 65 | LYN | 0.72802772 |
| 66 | PIK3CG | 0.72673765 |
| 67 | MAPK11 | 0.70424333 |
| 68 | CAMKK1 | 0.68678291 |
| 69 | TAOK3 | 0.68647116 |
| 70 | PDK1 | 0.66623464 |
| 71 | MARK3 | 0.66195667 |
| 72 | BRD4 | 0.65060841 |
| 73 | PRKCQ | 0.64634433 |
| 74 | CDK9 | 0.64537293 |
| 75 | MAPK12 | 0.64204691 |
| 76 | RPS6KC1 | 0.63976897 |
| 77 | RPS6KL1 | 0.63976897 |
| 78 | TRIB3 | 0.63840561 |
| 79 | MAPK4 | 0.58521050 |
| 80 | TAOK1 | 0.57900100 |
| 81 | STK24 | 0.56023500 |
| 82 | PRKAA2 | 0.55648435 |
| 83 | CDK4 | 0.54561445 |
| 84 | CDK6 | 0.53800331 |
| 85 | MATK | 0.53186242 |
| 86 | TTN | 0.51151417 |
| 87 | CLK1 | 0.50577284 |
| 88 | ABL1 | 0.50113139 |
| 89 | BMX | 0.49435461 |
| 90 | MAP3K11 | 0.46449552 |
| 91 | RPS6KA5 | 0.43734594 |
| 92 | PKN2 | 0.43443461 |
| 93 | FES | 0.42735603 |
| 94 | KDR | 0.41772670 |
| 95 | ADRBK2 | 0.40724672 |
| 96 | PRKCD | 0.40537779 |
| 97 | RPS6KA2 | 0.40341539 |
| 98 | EIF2AK2 | 0.39955954 |
| 99 | MAP3K1 | 0.39409863 |
| 100 | STK3 | 0.37640756 |
| 101 | HIPK2 | 0.37604969 |
| 102 | CDC42BPA | 0.37604713 |
| 103 | PASK | 0.37364821 |
| 104 | CDK12 | 0.36895977 |
| 105 | RPS6KA1 | 0.35843259 |
| 106 | MAP2K2 | 0.34705335 |
| 107 | MARK2 | 0.34019067 |
| 108 | EGFR | 0.33751341 |
| 109 | PDPK1 | 0.33618838 |
| 110 | FYN | 0.33033368 |
| 111 | MOS | 0.32741390 |
| 112 | MAP3K5 | 0.32320878 |
| 113 | PDGFRB | 0.32036687 |
| 114 | RPS6KB2 | 0.31605459 |
| 115 | RAF1 | 0.31509488 |
| 116 | MAP3K8 | 0.30956038 |
| 117 | BMPR1B | 0.30603711 |
| 118 | RPS6KA6 | 0.29963513 |
| 119 | DYRK1B | 0.29957774 |
| 120 | PRKG2 | 0.29474733 |
| 121 | RET | 0.27138881 |
| 122 | MAP2K6 | 0.26561998 |
| 123 | MELK | 0.26492364 |
| 124 | MAP3K7 | 0.25379145 |
| 125 | PKN1 | 0.25344564 |
| 126 | MAPK3 | 0.24545838 |
| 127 | INSR | 0.24134697 |
| 128 | IGF1R | 0.23786185 |
| 129 | FGR | 0.22187394 |
| 130 | IRAK2 | 0.22078227 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Allograft rejection_Homo sapiens_hsa05330 | 3.29526904 |
| 2 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 3.04609353 |
| 3 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.89513797 |
| 4 | Leishmaniasis_Homo sapiens_hsa05140 | 2.88628367 |
| 5 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.73731275 |
| 6 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.62083153 |
| 7 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.58827006 |
| 8 | Measles_Homo sapiens_hsa05162 | 2.47195221 |
| 9 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.34354266 |
| 10 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.23177016 |
| 11 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.20123889 |
| 12 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.17931341 |
| 13 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.05967341 |
| 14 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.99877831 |
| 15 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.97310756 |
| 16 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.95133636 |
| 17 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.92844043 |
| 18 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.90362060 |
| 19 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.90212839 |
| 20 | Legionellosis_Homo sapiens_hsa05134 | 1.83746368 |
| 21 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.78535696 |
| 22 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.75416837 |
| 23 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.73985283 |
| 24 | Influenza A_Homo sapiens_hsa05164 | 1.70272556 |
| 25 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.67767395 |
| 26 | Apoptosis_Homo sapiens_hsa04210 | 1.63749799 |
| 27 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.62894094 |
| 28 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.53344624 |
| 29 | Viral myocarditis_Homo sapiens_hsa05416 | 1.52206507 |
| 30 | Pertussis_Homo sapiens_hsa05133 | 1.51092008 |
| 31 | Tuberculosis_Homo sapiens_hsa05152 | 1.50958155 |
| 32 | Asthma_Homo sapiens_hsa05310 | 1.49832752 |
| 33 | Shigellosis_Homo sapiens_hsa05131 | 1.49593993 |
| 34 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.48537488 |
| 35 | Malaria_Homo sapiens_hsa05144 | 1.48032917 |
| 36 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.38354487 |
| 37 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.35315495 |
| 38 | Hepatitis B_Homo sapiens_hsa05161 | 1.30010439 |
| 39 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.25000730 |
| 40 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.21366789 |
| 41 | Salmonella infection_Homo sapiens_hsa05132 | 1.18111982 |
| 42 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.14185568 |
| 43 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.12281171 |
| 44 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.12155242 |
| 45 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.10862588 |
| 46 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.09315321 |
| 47 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.05403682 |
| 48 | Hepatitis C_Homo sapiens_hsa05160 | 1.05054518 |
| 49 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.04441767 |
| 50 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.00967597 |
| 51 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.99876391 |
| 52 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.89551458 |
| 53 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.89165824 |
| 54 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.88654991 |
| 55 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.87273898 |
| 56 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.85599120 |
| 57 | Platelet activation_Homo sapiens_hsa04611 | 0.85472044 |
| 58 | HTLV-I infection_Homo sapiens_hsa05166 | 0.84766326 |
| 59 | Ribosome_Homo sapiens_hsa03010 | 0.78949432 |
| 60 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.76323167 |
| 61 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.71472511 |
| 62 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.63321745 |
| 63 | Other glycan degradation_Homo sapiens_hsa00511 | 0.63209199 |
| 64 | Amoebiasis_Homo sapiens_hsa05146 | 0.53256055 |
| 65 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.53090615 |
| 66 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.48829682 |
| 67 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.48624663 |
| 68 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.47067311 |
| 69 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.46148757 |
| 70 | Lysosome_Homo sapiens_hsa04142 | 0.45808330 |
| 71 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.45176151 |
| 72 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.44681743 |
| 73 | * Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.43850009 |
| 74 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.42665219 |
| 75 | Phagosome_Homo sapiens_hsa04145 | 0.41301420 |
| 76 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.41017294 |
| 77 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.39919145 |
| 78 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.39864473 |
| 79 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.39776386 |
| 80 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.39741653 |
| 81 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.39436875 |
| 82 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.39263665 |
| 83 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.39076380 |
| 84 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.38370285 |
| 85 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.36704526 |
| 86 | Insulin resistance_Homo sapiens_hsa04931 | 0.34421648 |
| 87 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.34376730 |
| 88 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.34126946 |
| 89 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.32478409 |
| 90 | Colorectal cancer_Homo sapiens_hsa05210 | 0.32375456 |
| 91 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.32174096 |
| 92 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.32051555 |
| 93 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.31676169 |
| 94 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.31079302 |
| 95 | * Pathways in cancer_Homo sapiens_hsa05200 | 0.31005303 |
| 96 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.29420296 |
| 97 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.28111550 |
| 98 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.27769791 |
| 99 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.27569381 |
| 100 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.26982753 |
| 101 | Base excision repair_Homo sapiens_hsa03410 | 0.26854857 |
| 102 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.26296445 |
| 103 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.26048466 |
| 104 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.25563986 |
| 105 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.24542643 |
| 106 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.23723714 |
| 107 | Prostate cancer_Homo sapiens_hsa05215 | 0.23243077 |
| 108 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.22930477 |
| 109 | Endocytosis_Homo sapiens_hsa04144 | 0.22720062 |
| 110 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.21217789 |
| 111 | Prion diseases_Homo sapiens_hsa05020 | 0.21073940 |
| 112 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.20612073 |
| 113 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.20245294 |
| 114 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.17313227 |
| 115 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.16815368 |
| 116 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.16138255 |
| 117 | DNA replication_Homo sapiens_hsa03030 | 0.15724863 |

